NexGel Operating Income 2021-2024 | NXGL

NexGel operating income from 2021 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

NexGel Operating Income 2021-2024 | NXGL

NexGel operating income from 2021 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$213.1B
Intuitive Surgical (ISRG)$180.3B
Alcon (ALC)$45.3B
Edwards Lifesciences (EW)$40.7B
IQVIA Holdings (IQV)$38.1B
IDEXX Laboratories (IDXX)$34.3B
DexCom (DXCM)$27.5B
Waters (WAT)$23B
STERIS (STE)$22.2B
SONOVA HOLDING (SONVY)$21.9B
Hologic (HOLX)$19.1B
Fresenius Medical Care AG KGaA (FMS)$11.6B
Sysmex ADR (SSMXY)$11.5B
Globus Medical (GMED)$10.1B
Teleflex (TFX)$10B
Penumbra (PEN)$9B
Masimo (MASI)$7.7B
Glaukos (GKOS)$7.2B
PROCEPT BioRobotics (PRCT)$4.8B
Integer Holdings (ITGR)$4.2B
Inari Medical (NARI)$2.9B
LivaNova (LIVN)$2.8B
TransMedics (TMDX)$2.8B
Veracyte (VCYT)$2.6B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.1B
RxSight (RXST)$1.9B
Integra LifeSciences Holdings (IART)$1.5B
Alphatec Holdings (ATEC)$1.1B